Walking To Help Parkinson’s Research (NAPSA)—Scientists are constantly conducting research to discover new and improved treatments for Parkinson’s disease (PD), a pro- Thousandsof people are stepping up and stepping out to help fund Parkinson’s disease research. gressive neurological disorder. One wayto help raise money for research during April, Parkinson’s Disease Awareness Month, is to participate in or contribute to the Parkinson’s Unity Walk (PUW)in NewYork City taking place on April 16th. PUW is runby a grassroots orga- nization and is attended by more than 10,000 participants. All donations raised by walkers and contributors—millions of dollars over the past several years—go for research for PD. At this year’s event, mother, actress, talk show host, PD patient advocate and co-founderof the HollyRod Foundation, Holly Robinson Peete, will be at the Teva Neuroscience—sponsored AZILECT (rasagiline tablets) booth. AzILEcT is the first once-daily treatmentfor people with PD. PD is a debilitating disease affecting an estimated 500,000 Americans and can lead to symptoms suchas: Tremor on one side Slow movements Stiff limbs Balance problems. Currently, there is no cure for PD, but drugs relieve many symptoms of the disease. Learn more at www.unitywalk.org and AZILECT.com. AZILECT (rasagiline tablets) is indi- cated for the treatment of the signs and symptomsof Parkinson’s disease (PD) both asinitial therapy alone and to be added to levodopalater in the disease. IMPORTANT SAFETYINFORMATION ABOUT AZILECT Patients should not take AZILEcTif they are taking meperidineasit could result in a serious reaction such as comaor death. Also, patients should not take AZILECT with tramadol, methadone, propoxyphene, dextromethorphan,St.-John’s-wortor cyclobenzaprine. Patients should also not take AZILECT with other monoamine oxidase inhibitors (MAOIs). Patients should inform their physician if they are taking, or planning to take, any prescription or over-thecounter drugs, especially antidepressants and ciprofloxacin. If patients have moderateto severe liver disease, they should not take AZILECcT. Patients should not exceed a dose of 1 mg per day of AZILECT in order to prevent a possibly dangerousincrease in blood pressure. All PD patients should be monitored for melanoma(skin cancer) on a regular basis. Side effects seen with AZILECT alone are flu syndrome,joint pain, depression andindigestion; and when taken with levodopa are uncontrolled movements (dyskinesia), accidental injury, weight loss, low blood pressure when standing, vomiting, anorexia, joint pain, abdominal pain, nausea, constipation, dry mouth, rash, abnormal dreams,andfall. You are encouraged to report negative side effects of prescription drugs to the FDA.Visit www.fda.gov/med watchorcall 1-800-FDA-1088. To see full prescribing information, visit http://azilect.com/Resources/PDFs/ PrescribingInformation-pdf.aspx. AZL111030202/110522
